ES2159554T3 - Nuevos derivados gangliosidos y liso-gangliosidos o-sulfatados. - Google Patents

Nuevos derivados gangliosidos y liso-gangliosidos o-sulfatados.

Info

Publication number
ES2159554T3
ES2159554T3 ES94910741T ES94910741T ES2159554T3 ES 2159554 T3 ES2159554 T3 ES 2159554T3 ES 94910741 T ES94910741 T ES 94910741T ES 94910741 T ES94910741 T ES 94910741T ES 2159554 T3 ES2159554 T3 ES 2159554T3
Authority
ES
Spain
Prior art keywords
sub
derivatives
gangliosid
liso
acil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94910741T
Other languages
English (en)
Inventor
Aurelio Romeo
Gunter Kirschner
Carlo Chizzolini
Hari Manev
Laura Facci
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fidia SpA
Original Assignee
Fidia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia SpA filed Critical Fidia SpA
Application granted granted Critical
Publication of ES2159554T3 publication Critical patent/ES2159554T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Vascular Medicine (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

DERIVADOS DE GANGLIOSIDOS Y N-ACIL-N-LISO-GANGLIOSIDOS, DE N''ACIL-N''-LISO-GANGLIOSIDOS Y N,N''-DI- O POLI-ACIL-N.N''-DI-LISOGANGLIOSIDOSM EN LOS QUE AL MENS UNO DE LOS GRUPOS HIDROXILO EN LOS RESIDUOS DE CERAMIDA, SIALICOS O DE SACARIDO ES ESTERIFICADO CON ACIDO SULFURICO, SUS DERIVADOS FUNCIONALES, Y SUS SALES CON SUS BASES ORGANICAS E INORGANICAS Y LAS SALES DE ADICION, EXCEPTO LOS DERIVADOS PERSULFATADOS Y SUS GRUPOS CERAMIDA, SILIACO E HIDROXILO DE LOS GANGLIOSIDOS GM{SUB,1}, GD{SUB,1A}, GD{SUB,1B} Y GB{SUB,1B}. TALES COMPUESTOS TIENE ACTIVIDAD ANTINUEROTOXICA Y NEURITOGENCA Y PUEDEN POR CONSIGUIENTE USARSE EN PREPARACIONES FARMACEUTICAS. TAMBIEN SE HA PRESENTADO UN EFECTO DE MODULACION MARCADO SOBRE LA EXPRESION DE LA MOLECULA CD{SUB,4} EN CELULAS DE SISTEMA INMUNOLOGICO.
ES94910741T 1993-03-04 1994-03-04 Nuevos derivados gangliosidos y liso-gangliosidos o-sulfatados. Expired - Lifetime ES2159554T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT93PD000045A IT1267956B1 (it) 1993-03-04 1993-03-04 Derivati o-solfatati di gangliosidi e lisogangliosidi

Publications (1)

Publication Number Publication Date
ES2159554T3 true ES2159554T3 (es) 2001-10-16

Family

ID=11390210

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94910741T Expired - Lifetime ES2159554T3 (es) 1993-03-04 1994-03-04 Nuevos derivados gangliosidos y liso-gangliosidos o-sulfatados.

Country Status (10)

Country Link
EP (1) EP0688330B1 (es)
JP (1) JPH08507307A (es)
KR (1) KR960701073A (es)
AT (1) ATE204287T1 (es)
AU (1) AU694105B2 (es)
CA (1) CA2157359A1 (es)
DE (1) DE69427966T2 (es)
ES (1) ES2159554T3 (es)
IT (1) IT1267956B1 (es)
WO (1) WO1994020515A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1267955B1 (it) * 1993-03-04 1997-02-18 Fidia S P A In Amministrazione Derivati solfatati dei lisogangliosidi
US8481711B2 (en) 2010-07-06 2013-07-09 Hidenori Kamanishi Neurite outgrowth agent

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1238346B (it) * 1989-11-14 1993-07-13 Gangliosidi modificati e loro derivati funzionali.
JPH03246297A (ja) * 1990-02-22 1991-11-01 Nippon Koutai Kenkyusho:Kk ガングリオシド誘導体及びこれを含有する抗ｈｉｖ剤
IT1253832B (it) * 1991-08-01 1995-08-29 Fidia Spa Derivati di gangliosidi

Also Published As

Publication number Publication date
DE69427966D1 (de) 2001-09-20
ATE204287T1 (de) 2001-09-15
WO1994020515A1 (en) 1994-09-15
CA2157359A1 (en) 1994-09-15
EP0688330B1 (en) 2001-08-16
EP0688330A1 (en) 1995-12-27
IT1267956B1 (it) 1997-02-18
ITPD930045A0 (it) 1993-03-04
AU6352194A (en) 1994-09-26
ITPD930045A1 (it) 1994-09-04
JPH08507307A (ja) 1996-08-06
DE69427966T2 (de) 2002-04-04
AU694105B2 (en) 1998-07-16
KR960701073A (ko) 1996-02-24

Similar Documents

Publication Publication Date Title
BR9912694A (pt) Composto para preparar medicamento de administração pulmonar
ATE72991T1 (de) Nasale verabreichung von arzneimitteln.
BR9908081A (pt) Clipe adaptador, processos para montar um trilho auxiliar tendo uma fenda superior e uma fenda inferior a uma borda de prateleira e a um clipe adaptador, e para montar um clipe adaptador para acomodar um trilho auxiliar tendo uma fenda superior e uma fenda inferior a uma prateleira, trilho para acomodar uma etiqueta eletrônica de exposição, etiqueta para ser acomodada em um trilho e para expor informação a respeito de um produto associado, processo para acoplar uma etiqueta a um trilho, ferramenta para desacoplar etiqueta de um trilho, processo para desacoplar uma etiqueta de um trilho, e, conjunto para acoplar um sistema eletrônico de etiqueta de prateleira a uma borda de prateleira convencional
ES540177A0 (es) Sistema cerrado para administracion de medicinas
ES2090713T3 (es) Sales organicas de n,n'-diacetil-cistina.
PT96394A (pt) Processo para a preparacao de novos derivados do acido a-nor-esteroide-3-carboxilico e de composicoes farmaceuticas que os contem
ES2149254T3 (es) Modulacion especifica del sistema inmunitario.
ES2059789T3 (es) Esteroides sustituidos con acido fosfinico como inhibidores de la esteroide-5 alfa-reductasa.
BR8700678A (pt) Sistema e processo para exibir uma imagem e sistema para exibir um dado de figura
DK112287A (da) Anvendelse af 2-alkoxy-n-(1-azabicyclo-oe2,2,2aaoct-3-yl)-benzamider og -thiobenzamider samt farmaceutisk acceptable syreadditionssalte deraf som laegemidler
YU166790A (sh) Kompleksi koji imaju pomoćnu aktivnost
DE3682862D1 (de) Aerosolmittel zur nasenverstaeubung von vitamin b 12.
ES2159554T3 (es) Nuevos derivados gangliosidos y liso-gangliosidos o-sulfatados.
IT1195324B (it) Derivati encefalinici dotati di attivita' analgesica e composizioni farmaceutiche che li contengono
ES2100360T3 (es) Nuevos derivados de gangliosidos.
ES2143833T3 (es) Acidos y esteres de la diosmetina y composiciones farmaceuticas que los contienen.
SE7807054L (sv) Nya amidinopenicillansyraderivat, salter och estrar derav samt farmaceutiska kompositioner innehallande desamma
DK477685D0 (da) Peptidsubstituerede heterocycliske forbindelser og anvendelse deraf som immunostimulerende eller antiinfektive forbindelser samt farmaceutiske praeparater
ES2126155T3 (es) Nuevos compuestos aminoesteroidales que contienen uretano.
ES2055690T3 (es) Medicamento antihipoxico.
Neagle Peru: Primary & Secondary Teachers Announce Work Stoppage
ES2032301T3 (es) Procedimiento para la obtencion de los compuestos 3-piperinaminas o 3-azepinaminas sustituidas.
ES8402287A1 (es) Procedimiento de obtencion de nuevas carboxamidoguanidinas.
ATE182483T1 (de) Lernspiel
MU et al. Application of Caco-2 cell model in drug research

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 688330

Country of ref document: ES